Significant and Sustained Response with Short Cycle of Low-Dose Isotretinoin in Morbihan Disease

Skinmed. 2022 Apr 30;20(2):157-158. eCollection 2022.
No abstract available

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Dermatologic Agents* / therapeutic use
  • Humans
  • Isotretinoin / therapeutic use
  • Rosacea* / drug therapy

Substances

  • Dermatologic Agents
  • Isotretinoin